色黄素衍生物的合成、结构-活性关系以及对耐药白色念珠菌抗真菌活性的评价

IF 2.6 4区 医学 Q3 CHEMISTRY, MEDICINAL Medicinal Chemistry Research Pub Date : 2024-07-04 DOI:10.1007/s00044-024-03270-8
Yandan Wu, Luyi Jiang, Ruina Liu, Lijiao Yang, Fei Zou, Tianyu Zhang, Zefei Fan, Tianbao Zhang, Huan Yang, Shuyun Yin, Ruirui Wang, Ganpeng Li, Guanghui Ni
{"title":"色黄素衍生物的合成、结构-活性关系以及对耐药白色念珠菌抗真菌活性的评价","authors":"Yandan Wu,&nbsp;Luyi Jiang,&nbsp;Ruina Liu,&nbsp;Lijiao Yang,&nbsp;Fei Zou,&nbsp;Tianyu Zhang,&nbsp;Zefei Fan,&nbsp;Tianbao Zhang,&nbsp;Huan Yang,&nbsp;Shuyun Yin,&nbsp;Ruirui Wang,&nbsp;Ganpeng Li,&nbsp;Guanghui Ni","doi":"10.1007/s00044-024-03270-8","DOIUrl":null,"url":null,"abstract":"<div><p>With the increasing of <i>Candida albicans</i> infections year by year, and the widespread use of azole drugs, especially fluconazole has led to the emergence of drug resistance. Therefore, new antifungal agents are urgent needed. In this work, we synthesized a series of tryptanthrin derivatives, and all compounds were evaluated for antifungal activities against <i>Candida albicans</i> in vitro. The results indicated that most compounds combined with fluconazole showed good antifungal activity against drug-resistant <i>Candida albicans</i>. Especially, compound <b>5b</b> combined with fluconazole had an excellent synergistic effect, with MIC<sub>50</sub> value of 0.94 μg/mL, and the FICI value of 0.005. Further mechanism study demonstrated that compound <b>5b</b> significantly inhibited the hyphal growth and biofilm formation of <i>Candida albicans</i>. Compound <b>5b</b> combined with fluconazole could be considered as a novel antifungal agent.</p></div>","PeriodicalId":699,"journal":{"name":"Medicinal Chemistry Research","volume":"33 9","pages":"1598 - 1610"},"PeriodicalIF":2.6000,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synthesis, structure-activity relationship and evaluation of antifungal activity of tryptanthrin derivatives against drug-resistant Candida albicans\",\"authors\":\"Yandan Wu,&nbsp;Luyi Jiang,&nbsp;Ruina Liu,&nbsp;Lijiao Yang,&nbsp;Fei Zou,&nbsp;Tianyu Zhang,&nbsp;Zefei Fan,&nbsp;Tianbao Zhang,&nbsp;Huan Yang,&nbsp;Shuyun Yin,&nbsp;Ruirui Wang,&nbsp;Ganpeng Li,&nbsp;Guanghui Ni\",\"doi\":\"10.1007/s00044-024-03270-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>With the increasing of <i>Candida albicans</i> infections year by year, and the widespread use of azole drugs, especially fluconazole has led to the emergence of drug resistance. Therefore, new antifungal agents are urgent needed. In this work, we synthesized a series of tryptanthrin derivatives, and all compounds were evaluated for antifungal activities against <i>Candida albicans</i> in vitro. The results indicated that most compounds combined with fluconazole showed good antifungal activity against drug-resistant <i>Candida albicans</i>. Especially, compound <b>5b</b> combined with fluconazole had an excellent synergistic effect, with MIC<sub>50</sub> value of 0.94 μg/mL, and the FICI value of 0.005. Further mechanism study demonstrated that compound <b>5b</b> significantly inhibited the hyphal growth and biofilm formation of <i>Candida albicans</i>. Compound <b>5b</b> combined with fluconazole could be considered as a novel antifungal agent.</p></div>\",\"PeriodicalId\":699,\"journal\":{\"name\":\"Medicinal Chemistry Research\",\"volume\":\"33 9\",\"pages\":\"1598 - 1610\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinal Chemistry Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s00044-024-03270-8\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry Research","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00044-024-03270-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

随着白色念珠菌感染的逐年增加,以及唑类药物尤其是氟康唑的广泛使用,导致了耐药性的出现。因此,迫切需要新的抗真菌药物。在这项工作中,我们合成了一系列胰黄素衍生物,并对所有化合物进行了体外抗白色念珠菌活性评价。结果表明,大多数化合物与氟康唑联用对耐药白色念珠菌具有良好的抗真菌活性。特别是化合物 5b 与氟康唑联用具有很好的协同作用,MIC50 值为 0.94 μg/mL,FICI 值为 0.005。进一步的机理研究表明,化合物 5b 能显著抑制白色念珠菌的菌丝生长和生物膜形成。化合物 5b 与氟康唑联用可被视为一种新型抗真菌剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Synthesis, structure-activity relationship and evaluation of antifungal activity of tryptanthrin derivatives against drug-resistant Candida albicans

With the increasing of Candida albicans infections year by year, and the widespread use of azole drugs, especially fluconazole has led to the emergence of drug resistance. Therefore, new antifungal agents are urgent needed. In this work, we synthesized a series of tryptanthrin derivatives, and all compounds were evaluated for antifungal activities against Candida albicans in vitro. The results indicated that most compounds combined with fluconazole showed good antifungal activity against drug-resistant Candida albicans. Especially, compound 5b combined with fluconazole had an excellent synergistic effect, with MIC50 value of 0.94 μg/mL, and the FICI value of 0.005. Further mechanism study demonstrated that compound 5b significantly inhibited the hyphal growth and biofilm formation of Candida albicans. Compound 5b combined with fluconazole could be considered as a novel antifungal agent.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicinal Chemistry Research
Medicinal Chemistry Research 医学-医药化学
CiteScore
4.70
自引率
3.80%
发文量
162
审稿时长
5.0 months
期刊介绍: Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of molecular biology.
期刊最新文献
Synthesis of new Michael acceptors with cinnamamide scaffold as potential anti-breast cancer agents: cytotoxicity and ADME in silico studies Iridoid for drug discovery: Structural modifications and bioactivity studies Synthesis and antiproliferative activity of 7-substituted amide estradiol derivatives Correction: Substituted furan-carboxamide and Schiff base derivatives as potential hypolipidemic compounds: evaluation in Triton WR-1339 hyperlipidemic rat model Quinazolinone-based subchemotypes for targeting HIV-1 capsid protein: design and synthesis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1